Pharma Giant Cipla Explores Billion-Dollar Stake Sale To Blackstone, Baring Asia: Report

Promoters of pharmaceutical major Cipla are reportedly in discussions with major private equity (PE) firms to sell a portion of their total stake in the company, Moneycontrol reported.

The move is seen as a step towards succession planning for the company.

What Happened? PE firms such as Blackstone and Baring Asia are among those in talks to explore a deal. The promoters currently own a 33.47% stake in Cipla. With Cipla’s market capitalisation exceeding $10 billion, a 25% stake sale would require a substantial investment of over $2.5 billion.

Given the age of the second-generation promoters, YK Hamied and MK Hamied, and with Samina Hamied being the only member from the second generation leading Cipla, the company is in need of a clear succession plan.

Price Action: Cipla’s share price was trading 11.19% higher at ₹1,188.10 in afternoon trade on Thursday

Read Next: Exclusive: This Architect-Turned-Entrepreneur Wants To Help You Escape Into Nature In A Tiny Home

News that Moves

Get Ring The Bell, Benzinga India’s weekly briefing. Designed specifically for investors like you.

You have successfully subscribed.
Posted In: EquitiesNewsHealth CareAsset SalesMarketsGeneralBaring AsiablackstoneCipla